Results 1 to 10 of about 9,938 (160)

Efficacy of argatroban plus alteplase versus intravenous alteplase according to diabetes mellitus in acute ischemic stroke [PDF]

Scientific Reports
We conducted a post hoc analysis of the ARAIS (Argatroban Plus Recombinant Tissue-Type Plasminogen Activator for AIS) trial to investigate whether diabetes mellitus (DM) affects the efficacy of argatroban plus alteplase in patients with acute ischaemic ...
Xiao-Wen Hou, Yu Cui, Nan-Nan Zhang, Hui-Sheng Chen   +3 more
doaj   +2 more sources

Comparative effectiveness of Tenecteplase and Alteplase for ischemic stroke: real-world data from a stroke center [PDF]

BMC Neurology
Background Tenecteplase (TNK) and Alteplase (rt-PA) are intravenous thrombolytics used in acute ischemic stroke (AIS). While Alteplase has long been the standard of care, TNK is now also approved for AIS by both the EMA and FDA.
Toska Maxhuni, Francesca Culaj, Merve-Melis Sayar, Priyanka Böttger, Samra Hamzic, Stefan T. Gerner, Tobias Braun, Maxime Viard, Martin Juenemann, Heidrun H. Krämer, Omar AlHaj Omar   +10 more
doaj   +2 more sources

Low-dose vs. standard-dose alteplase for Chinese patients with acute ischemic stroke: A propensity score analysis

Frontiers in Neurology, 2023
Background and purposePrevious studies have stimulated debates on low-dose alteplase administration in acute ischemic stroke (AIS) among the Asian population.
Jiawen Xu, Xi Chen, Yanan Xie, Yi Wang, Shidong Chen, Qiang Dong, Yi Dong, Kun Fang   +7 more
doaj   +1 more source

Outcomes and Treatment Complications of Intravenous Urokinase Thrombolysis in Acute Ischemic Stroke in China

Frontiers in Neurology, 2021
Background: Intravenous thrombolysis with alteplase benefits eligible patients with acute ischemic stroke. However, in some countries such as China, alteplase may be too expensive for low-income patients, and also for regions with low economic ...
Rongrong Zhang, Hui Wei, Yu Ren, Yanping Wu, Yetao Luo, Lei Zhang, Yingchao Huo, Jinzhou Feng, Philippe P. Monnier, Philippe P. Monnier, Philippe P. Monnier, Xinyue Qin   +11 more
doaj   +1 more source

Tenecteplase Thrombolysis in Posterior Circulation Stroke

Frontiers in Neurology, 2021
One in five ischaemic strokes affects the posterior circulation. Basilar artery occlusion is a type of posterior circulation stroke associated with a high risk of disability and mortality.
Fana Alemseged, Bruce C. V. Campbell
doaj   +1 more source

A comparison of low- versus standard-dose bridging alteplase in acute ischemic stroke mechanical thrombectomy using indirect methods

Therapeutic Advances in Neurological Disorders, 2023
Background: Whether low-dose alteplase is similar to standard-dose bridging alteplase prior to endovascular mechanical thrombectomy in patients with acute ischemic stroke (AIS) remains uncertain.
Wei Zheng, Hanhan Lei, Gareth Ambler, David J. Werring, Huiying Lin, Xiaojuan Lin, Yi Tang, Jing Wu, Zhaomin Lin, Nan Liu, Houwei Du   +10 more
doaj   +1 more source

Using Tenecteplase for Acute Ischemic Stroke: What Is the Hold Up?

Western Journal of Emergency Medicine, 2020
Alteplase is the only Food and Drug Administration-approved intravenous (IV) thrombolytic medication for acute ischemic stroke. However, multiple recent studies comparing tenecteplase and alteplase suggest that tenecteplase is at least as efficacious as ...
Tony Zitek, Ramsey Ataya, Isabel Brea
doaj   +1 more source

Different doses of tenecteplase vs. alteplase for acute ischemic stroke within 4.5 hours of symptom onset: a network meta-analysis of randomized controlled trials

Frontiers in Neurology, 2023
BackgroundThe optimal dose of tenecteplase vs. alteplase for acute ischemic stroke (AIS) has yet to be established. Therefore, we included the latest randomized controlled trials (RCT) to assess the efficacy and safety of different doses of tenecteplase ...
Huo Liang, Xue Wang, Xuemei Quan, Shijian Chen, Bin Qin, Shuolin Liang, Qiuhui Huang, Jian Zhang, Zhijian Liang   +8 more
doaj   +1 more source

Tenecteplase vs. alteplase for acute ischemic stroke: a systematic review

International Journal of Emergency Medicine, 2022
Introduction Thrombolysis for acute ischemic stroke (AIS) with alteplase is the currently approved therapy for patients who present within 4.5 h of symptom onset and meet criteria.
Neha Potla, Latha Ganti
doaj   +1 more source

Low-Dose vs. Standard-Dose Intravenous Alteplase in Bridging Therapy Among Patients With Acute Ischemic Stroke: Experience From a Stroke Center in Vietnam

Frontiers in Neurology, 2021
Background: To date, the role of bridging intravenous thrombolysis before mechanical thrombectomy (MTE) is controversial but still recommended in eligible patients.
Duy Ton Mai, Duy Ton Mai, Viet Phuong Dao, Van Chi Nguyen, Van Chi Nguyen, Dang Luu Vu, Dang Luu Vu, Tien Dung Nguyen, Xuan Trung Vuong, Quoc Viet Bui, Ha Quan Phan, Quang Tho Pham, Hoang Kien Le, Anh Tuan Tran, Quang Anh Nguyen, Phuc Duc Dang, Hoang Nguyen, Hoang Thi Phan, Hoang Thi Phan   +18 more
doaj   +1 more source